Jon Lieber | U.S. Chief Financial Officer |
Roger Garceau | Interim CEO |
Phillip Schwartz | President of R&D |
Arthur Santora | Chief Medical Officer |
Good morning, and welcome to Entera Bio's Conference Call to discuss the Financial and Operating Results from the Third Quarter of 2020. At this time, all participants lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to turn the call over to Jon Lieber, the U.S.-based CFO of Entera.